Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens
T. Mayadas, V. Mysore, X. Cullere, M. L. Settles, M. Kattan, X. Ji, M. Desjardins, B. Durbin-Johnson, T. Gilboa, L. Baden, D. Walt, L. Andrew, L. Jehi
This study shows that prior MMR and Tdap vaccinations generate cross-reactive T cells that reduce severe COVID-19 outcomes.
bioRxiv · May 3, 2021Immunology